UNCOOKED ALERT: Reata Pharmaceuticals Inc said to ... - Part 3
Biogen, a US-listed pharmaceutical giant, has now announced the purchase of Reata Pharmaceuticals Inc for $7.3 billion. Below is a link to today's press release.
Little old Betaville wonders, though, whether Reata's other rumoured suitor (see Part 1) will step out of the shadows?
Or will Biogen's offer prove to be a knock out?..
Date: Friday, 28 July 2023, 6:26 pm